Whitehawk Therapeutics (WHWK) Retained Earnings (2010 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly Retained Earnings came in at -$15000.0 in Q1 2026, up 99.99% year-on-year from -$7500.2 in Q1 2025, and down 112.5% on a QoQ basis from $120000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Retained Earnings (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Retained Earnings data on file, last reported at -$15000.0 in Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.99% year-over-year to -$15000.0 in Q1 2026; TTM through Mar 2026 was -$15000.0, a 99.99% increase from a year earlier, with the FY2025 full-year figure at $120000.0, up 100.04% from the prior year.
- Retained Earnings for Q1 2026 stood at -$15000.0, down from $120000.0 in the prior quarter.
- Over the last five years, Retained Earnings for WHWK reached as high as $120000.0 in Q4 2025 and fell as low as -$332.7 million in Q4 2024.
- Historically, Retained Earnings has averaged -$195.5 million across 5 years, with a median of -$236.4 million in 2023.
- Across the five-year window, Retained Earnings slumped 233780.87% in 2023 and surged 100.04% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$115000.0 in 2022, then slumped by 233780.87% to -$269.0 million in 2023, then declined by 23.68% to -$332.7 million in 2024, then soared by 100.04% to $120000.0 in 2025, then sank by 112.5% to -$15000.0 in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$15000.0 in Q1 2026, $120000.0 in Q4 2025, and -$330.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - | -15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | -330.00 Mn |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | -259.60 Mn |
| Dec 31, 2024 | -332.65 Mn |
| Sep 30, 2024 | -314.38 Mn |
| Jun 30, 2024 | -301.80 Mn |
| Mar 31, 2024 | -287.30 Mn |
| Dec 31, 2023 | -268.96 Mn |
| Sep 30, 2023 | -252.70 Mn |
| Jun 30, 2023 | -236.39 Mn |
| Mar 31, 2023 | -218.40 Mn |
| Dec 31, 2022 | -115,000.00 |
| Sep 30, 2022 | -189.30 Mn |
| Jun 30, 2022 | -174.80 Mn |
| Mar 31, 2022 | -156.54 Mn |
| Dec 31, 2021 | -142.69 Mn |
| Sep 30, 2021 | -126.70 Mn |
| Jun 30, 2021 | -155.40 Mn |